Rating History for Sigilon Therapeutics (SGTX) by Canaccord
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/18/2023 | Whitney Ijem | New Coverage | Buy (N/A) |
N/A (N/A) |
0.41 (22.47) |
5380.49% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/18/2023 | Whitney Ijem | New Coverage | Buy (N/A) |
N/A (N/A) |
0.41 (22.47) |
5380.49% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||